CHF 99.49
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E
Target Price
The average target price of NOVN.SW is 94 and suggests 5% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to dec
